Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$0.07 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 158,360 shares changing hands.
Resverlogix Stock Performance
The stock has a fifty day moving average price of C$0.07 and a 200-day moving average price of C$0.06. The firm has a market capitalization of C$16.62 million, a PE ratio of -1.20 and a beta of 0.77.
Resverlogix (TSE:RVX – Get Free Report) last announced its earnings results on Wednesday, August 14th. The biotechnology company reported C($0.02) earnings per share for the quarter. Research analysts expect that Resverlogix Corp. will post -0.22 earnings per share for the current fiscal year.
About Resverlogix
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.
Recommended Stories
- Five stocks we like better than Resverlogix
- What Investors Need to Know to Beat the Market
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- What Are Dividend Achievers? An Introduction
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- How to invest in marijuana stocks in 7 steps
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
